{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:37:25Z","timestamp":1648535845058},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T00:00:00Z","timestamp":1289952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00108-010-2716-0","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T03:36:41Z","timestamp":1289792201000},"page":"1510-1515","source":"Crossref","is-referenced-by-count":3,"title":["Behandlung nicht mit zystischer Fibrose assoziierter Bronchiektasen (Non-CF-Bronchiektasen)"],"prefix":"10.1007","volume":"51","author":[{"given":"J.","family":"Rademacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,17]]},"reference":[{"key":"2716_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thorax.57.1.15","volume":"57","author":"Angrill","year":"2002","unstructured":"Angrill J, Augusti C, Celis R de et al (2002) Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 57:15\u201319","journal-title":"Thorax"},{"key":"2716_CR2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1055\/s-0030-1249941","volume":"58","author":"Bagheri","year":"2009","unstructured":"Bagheri R, Haghi SZ, Fattahi Masoum SH et al (2009) Surgical management of bronchiectasis: Analysis of 277 patients. J Thorac Cardiovasc Surg 58:291\u2013294","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2716_CR3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","volume":"162","author":"Barker","year":"2000","unstructured":"Barker AF, Couch L, Fiel SB et al (2000) Tobramycin solution for inhalation reduces sputum pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 162:481\u2013485","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR4","first-page":"A3214","volume":"179","author":"Bilton","year":"2009","unstructured":"Bilton D, Bruinenberg P, Otulana B et al (2009) Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum pseudomonas aeruginosa density in CF and non-CF bronchiectasis. Am J Respir Crit Care Med 179:A3214","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ppul.10104","volume":"33","author":"Callahan","year":"2002","unstructured":"Callahan CW, Redding GJ (2002) Bronchiectasis in children: orphan disease or persistent problem? Pediatr Pulmonol 33:492\u2013496","journal-title":"Pediatr Pulmonol"},{"key":"2716_CR6","first-page":"CD000052","volume":"19","author":"Cates","year":"2006","unstructured":"Cates CJ, Crilly JA, Rowe BH (2006) Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 19:CD000052","journal-title":"Cochrane Database Syst Rev"},{"key":"2716_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1479972308091823","volume":"5","author":"Courtney","year":"2008","unstructured":"Courtney JM, Kelly MG, Watt A et al (2008) Quality of life and inflammation in exacerbations of bronchiectasis. Chron Respir Dis 5:161\u2013168","journal-title":"Chron Respir Dis"},{"key":"2716_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-2999(01)01321-8","volume":"429","author":"Culic","year":"2001","unstructured":"Culic O, Erakovic V, Parnham MJ (2001) Anti-inflammatory effects of macrolide antibiotics. Eur J Pharacol 429:209\u2013229","journal-title":"Eur J Pharacol"},{"key":"2716_CR9","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.159.6.9809074","volume":"159","author":"Daviskas","year":"1999","unstructured":"Daviskas E, Anderson SD, Eberl S et al (1999) Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med 159:1843\u20131848","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","volume":"10","author":"Daviskas","year":"2005","unstructured":"Daviskas E, Anderson SD, Gomes K et al (2005) Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology 10:46\u201356","journal-title":"Respirology"},{"key":"2716_CR11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","volume":"354","author":"Donaldson","year":"2006","unstructured":"Donaldson SH, Bennett WD, Zeman KL et al (2006) Mucus clearance an lung function in cystic fibrosis with hypertonic saline. N Engl J Med 354:241\u2013250","journal-title":"N Engl J Med"},{"key":"2716_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/JAS-120002199","volume":"39","author":"Ekici","year":"2002","unstructured":"Ekici A, Ekici M, Erdemoglu AK (2002) Effect of azithromycin on the severity of bronchial hyperresponsiveness in patients with mild asthma. J Asthma 39:181","journal-title":"J Asthma"},{"key":"2716_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","volume":"354","author":"Elkins","year":"2006","unstructured":"Elkins MR, Robinson M, Rose BR et al (2006) A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 354:229\u2013240","journal-title":"N Engl J Med"},{"key":"2716_CR14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10405-006-0124-x","volume":"3","author":"F\u00fchner","year":"2006","unstructured":"F\u00fchner T, Pletz MW, Welte T (2006) Bronchiektasen. Pneumologe 3:487\u2013496","journal-title":"Pneumologe"},{"key":"2716_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10405-005-0079-3","volume":"3","author":"F\u00fchner","year":"2006","unstructured":"F\u00fchner T, Pletz MW, Welte T (2006) Exazerbation bei Bronchiektasen und zystischer Fibrose. Pneumologe 3:37\u201345","journal-title":"Pneumologe"},{"key":"2716_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","volume":"110","author":"Greenberger","year":"2002","unstructured":"Greenberger PA (2002) Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 110:685\u2013692","journal-title":"J Allergy Clin Immunol"},{"key":"2716_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0b013e3282f4f237","volume":"21","author":"Ilowite","year":"2008","unstructured":"Ilowite J, Spiegler P, Chawla S (2008) Bronchiectasis: new findings in the pathogenesis and treatment of this disease. Curr Opin Infect Dis 21:163\u2013167","journal-title":"Curr Opin Infect Dis"},{"key":"2716_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2004.05.006","volume":"99","author":"Kellett","year":"2005","unstructured":"Kellett F, Redfern J, Niven RM (2005) Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Resp Med 99:27\u201331","journal-title":"Resp Med"},{"key":"2716_CR19","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","volume":"157","author":"Kudoh","year":"1998","unstructured":"Kudoh S, Azuma A, Yamamoto M et al (1998) Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157:1829\u20131832","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jac\/dkp282","volume":"64","author":"MacLeod","year":"2009","unstructured":"MacLeod DL, Barker LM, Sutherland JL et al (2009) Antibacterial activities of a fosfomycin\/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother 64:829\u2013836","journal-title":"J Antimicrob Chemother"},{"key":"2716_CR21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1378\/chest.115.4.996","volume":"115","author":"Mal","year":"1999","unstructured":"Mal H, Rullon I, Mellot F et al (1999) Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 115:996\u20131001","journal-title":"Chest"},{"key":"2716_CR22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1164\/rccm.200712-1804OC","volume":"178","author":"McCoy","year":"2008","unstructured":"McCoy KS, Quittner AL, Oermann CM et al (2008) Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med 178:921\u2013928","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1753465810366858","volume":"4","author":"Metersky","year":"2010","unstructured":"Metersky M (2010) New treatment options for bronchiectasis. Ther Adv Respir Dis 4:93\u201399","journal-title":"Ther Adv Respir Dis"},{"key":"2716_CR24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/thorax.55.8.635","volume":"55","author":"O","year":"2000","unstructured":"O\u2019Brien C, Guest PJ, Hill SL et al (2000) Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 55:635\u2013642","journal-title":"Thorax"},{"key":"2716_CR25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","volume":"113","author":"O","year":"1998","unstructured":"O\u2019Donell AE, Barker AF, Ilowite JS et al (1998) Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 113:1329\u20131334","journal-title":"Chest"},{"key":"2716_CR26","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1183\/09031936.00107108","volume":"34","author":"O","year":"2009","unstructured":"O\u2019Donell AE, Swarnakar R, Yahina L et al (2009) A placebo- controlled study of liposomal amikacin for inhalation nebulised once daily in the treatment of bronchiectatic patients with chronic Pseudomonas aeruginosa lung infection. Eur Repir J 34:231S","journal-title":"Eur Repir J"},{"key":"2716_CR27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200305-648OC","volume":"170","author":"Patel","year":"2004","unstructured":"Patel IS, Vlahos I, Wilkinson TM et al (2004) Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170:400\u2013407","journal-title":"Am J Respir Crit Care Med"},{"key":"2716_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","volume":"340","author":"Ramsey","year":"1999","unstructured":"Ramsey BW, Pepe MS, Quan JM et al (1999) Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 340:23\u201330","journal-title":"N Engl J Med"},{"key":"2716_CR29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thx.2009.121657","volume":"65","author":"Ratjen","year":"2010","unstructured":"Ratjen F, Munck A, Kho P, Angyalosi G; ELITE Study Group (2010) Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE Trial. Thorax 65:286\u2013291","journal-title":"Thorax"},{"key":"2716_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jac\/34.1.149","volume":"34","author":"Rayner","year":"1994","unstructured":"Rayner CF, Tillotson G, Cole PJ et al (1994) Efficacy and safety of longterm ciprofloxacin in the management of severe bronchiectasis. Antimicrob Chemother 34:149\u2013156","journal-title":"Antimicrob Chemother"},{"key":"2716_CR31","first-page":"169","volume":"1","author":"Rubin","year":"2000","unstructured":"Rubin BK, Tamaoki J (2000) Macrolide antibiotics as biological response modifiers. Curr Opin Investig Drugs 1:169\u2013172","journal-title":"Curr Opin Investig Drugs"},{"key":"2716_CR32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0954-6111(97)90251-1","volume":"91","author":"Saynajakangas","year":"1997","unstructured":"Saynajakangas O, Keistinen T, Tuuponen T, Kivela SL (1997) Bronchiectasis in Finland: trends in hospital treatment. Resp Med 91:395\u2013398","journal-title":"Resp Med"},{"key":"2716_CR33","first-page":"1420","volume":"127","author":"Scheinberg","year":"2005","unstructured":"Scheinberg P, Shore E (2005) A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 127:1420\u20131426","journal-title":"Chest"},{"key":"2716_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","volume":"28","author":"Sethi","year":"2010","unstructured":"Sethi S, Jones PW, Theron MS et al (2010) Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 28:10","journal-title":"Respir Res"},{"key":"2716_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","volume":"117","author":"Shinkai","year":"2008","unstructured":"Shinkai M, Henke MO, Rubin BK (2008) Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 117:393\u2013405","journal-title":"Pharmacol Ther"},{"key":"2716_CR36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","volume":"60","author":"Soler-Cataluna","year":"2005","unstructured":"Soler-Cataluna JJ, Mart\u00ednez-Garc\u00eda MA, Rom\u00e1n S\u00e1nchez P et al (2005) Severe acute exacerbations and mortality in patients with obstructive pulmonary disease. Thorax 60:925\u2013931","journal-title":"Thorax"},{"key":"2716_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2007.01404.x","volume":"37","author":"Steinfort","year":"2007","unstructured":"Steinfort DP, Steinfort C (2007) Effect of long-term nebulised colistin of lung function and quality of life in patients with chronic bronchial sepsis. Intern Med J 37:495\u2013498","journal-title":"Intern Med J"},{"key":"2716_CR38","first-page":"pii","volume":"Evid","author":"Ten","year":"2008","unstructured":"Ten Hacken N, Kerstjens H, Postma D (2008) Bronchiectasis. Clin Evid (Online):pii 1507","journal-title":"Clin"},{"key":"2716_CR39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/thx.2002.003236","volume":"60","author":"Tsang","year":"2005","unstructured":"Tsang KW, Tan KC, Ho PL et al (2005) Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 60:239\u2013243","journal-title":"Thorax"},{"key":"2716_CR40","first-page":"691","volume":"8","author":"Tsang","year":"2004","unstructured":"Tsang KW, Tipoe GL (2004) Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis 8:691\u2013702","journal-title":"Int J Tuberc Lung Dis"},{"key":"2716_CR41","doi-asserted-by":"crossref","unstructured":"Welte T (2005) Bronchiektasen. In: Sch\u00f6lmerich J (Hrsg) Medizinische Therapie, 2. Aufl. Springer, Berlin Heidelberg New York, S 995\u20131000","DOI":"10.1007\/3-540-27385-9_106"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-010-2716-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-010-2716-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:12:19Z","timestamp":1558570339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-010-2716-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,17]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1007\/s00108-010-2716-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,17]]}}}